Granzyme B in injury, inflammation, and repair.

[1]  P. Calabresi,et al.  Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel , 2012, PloS one.

[2]  K. Nagaraju,et al.  Platelets Induce Apoptosis during Sepsis in a Contact-Dependent Manner That Is Inhibited by GPIIb/IIIa Blockade , 2012, PloS one.

[3]  A. Caplan,et al.  Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition. , 2012, The Biochemical journal.

[4]  J. Trapani,et al.  This information is current as Granzyme B Activated Mouse B Cells Lack Expression of Hawkins and , 2012 .

[5]  D. Knight,et al.  Granzyme B Cleaves Decorin, Biglycan and Soluble Betaglycan, Releasing Active Transforming Growth Factor-β1 , 2012, PloS one.

[6]  G. Pawelec,et al.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. , 2012, Vaccine.

[7]  E. Tredget,et al.  Reduced Decorin, Fibromodulin, and Transforming Growth Factor-&bgr;3 in Deep Dermis Leads to Hypertrophic Scarring , 2012, Journal of burn care & research : official publication of the American Burn Association.

[8]  J. Pfeilschifter,et al.  Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 and MicroRNA-21 , 2011, Science Signaling.

[9]  S. Cullen,et al.  Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α. , 2011, Molecular cell.

[10]  K. Midwood,et al.  Plasma and cellular fibronectin: distinct and independent functions during tissue repair , 2011, Fibrogenesis & tissue repair.

[11]  B. McManus,et al.  Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm , 2011, Cell Death and Disease.

[12]  D. Knight,et al.  Granzyme K Activates Protease-Activated Receptor-1 , 2011, PloS one.

[13]  K. Preissner,et al.  Vitronectin in Vascular Context: Facets of a Multitalented Matricellular Protein , 2011, Seminars in thrombosis and hemostasis.

[14]  Thomas Abraham,et al.  Granzyme B contributes to extracellular matrix remodeling and skin aging in apolipoprotein E knockout mice , 2011, Experimental Gerontology.

[15]  C. Borner,et al.  Mouse granzyme K has pro-inflammatory potential , 2011, Cell Death and Differentiation.

[16]  H. Hyakusoku,et al.  A case of von Willebrand disease discovered during treatment of a sacral pressure ulcer. , 2010, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[17]  S. Akira,et al.  A Role for Granzyme M in TLR4-Driven Inflammation and Endotoxicosis , 2010, The Journal of Immunology.

[18]  E. Gabazza,et al.  Granzyme B is a novel interleukin-18 converting enzyme. , 2010, Journal of dermatological science.

[19]  S. Chan,et al.  Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis. , 2010, The Journal of trauma.

[20]  S. Williams,et al.  Granzymes in age-related cardiovascular and pulmonary diseases , 2010, Cell Death and Differentiation.

[21]  B. McManus,et al.  Perforin-independent extracellular granzyme B activity contributes to abdominal aortic aneurysm. , 2010, The American journal of pathology.

[22]  A. Utani,et al.  Elastic fiber assembly is disrupted by excessive accumulation of chondroitin sulfate in the human dermal fibrotic disease, keloid. , 2009, Biochemical and biophysical research communications.

[23]  D. Granville,et al.  Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma , 2009, Laboratory Investigation.

[24]  Julia Maier,et al.  Human B Cells Secrete Granzyme B When Recognizing Viral Antigens in the Context of the Acute Phase Cytokine IL-211 , 2009, The Journal of Immunology.

[25]  Ye-yang Li,et al.  Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts. , 2009, Burns : journal of the International Society for Burn Injuries.

[26]  P. Bird,et al.  Active and zymogen forms of granzyme B are constitutively released from cytotoxic lymphocytes in the absence of target cell engagement , 2009, Immunology and cell biology.

[27]  M. Simon,et al.  Granule-associated serine proteases: granzymes might not just be killer proteases. , 2009, Trends in immunology.

[28]  Lianfa Shi,et al.  Human and mouse granzyme A induce a proinflammatory cytokine response. , 2008, Immunity.

[29]  P. Bird,et al.  Antihemostatic Activity of Human Granzyme B Mediated by Cleavage of von Willebrand Factor* , 2008, Journal of Biological Chemistry.

[30]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[31]  W. Parks,et al.  Metalloproteinases and their inhibitors: regulators of wound healing. , 2008, The international journal of biochemistry & cell biology.

[32]  Olena Kravchuk,et al.  Vitronectin: growth factor complexes hold potential as a wound therapy approach. , 2008, The Journal of investigative dermatology.

[33]  L. Harkless,et al.  Fibronectin fragmentation is a feature of periodontal disease sites and diabetic foot and leg wounds and modifies cell behavior. , 2008, Journal of periodontology.

[34]  W. Carter,et al.  Keratinocyte Migration, Proliferation, and Differentiation in Chronic Ulcers From Patients With Diabetes and Normal Wounds , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[35]  Michael Simons,et al.  Antiangiogenic plasma activity in patients with systemic sclerosis. , 2007, Arthritis and rheumatism.

[36]  C. Hack,et al.  Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. , 2007, Molecular immunology.

[37]  H. Zentgraf,et al.  Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin , 2007, Cell Death and Differentiation.

[38]  C. Jean,et al.  UVA Induces Granzyme B in Human Keratinocytes through MIF , 2007, Journal of Biological Chemistry.

[39]  James C. Whisstock,et al.  The major human and mouse granzymes are structurally and functionally divergent , 2006, The Journal of cell biology.

[40]  J. Virchow,et al.  Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. , 2006, Blood.

[41]  R. Iozzo,et al.  A role for decorin in cutaneous wound healing and angiogenesis , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[42]  C. Jean,et al.  Human Keratinocytes Acquire Cellular Cytotoxicity under UV-B Irradiation , 2006, Journal of Biological Chemistry.

[43]  C. Jackson,et al.  Targeting matrix metalloproteases to improve cutaneous wound healing , 2006, Expert opinion on therapeutic targets.

[44]  Marian F Young,et al.  The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. , 2005, The Journal of clinical investigation.

[45]  J. Trapani,et al.  Extracellular Matrix Remodeling by Human Granzyme B via Cleavage of Vitronectin, Fibronectin, and Laminin* , 2005, Journal of Biological Chemistry.

[46]  David C. Gondek,et al.  Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism1 , 2005, The Journal of Immunology.

[47]  B. McManus,et al.  Granzyme B Induces Smooth Muscle Cell Apoptosis in the Absence of Perforin: Involvement of Extracellular Matrix Degradation , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[48]  R. Rossen,et al.  Impact of Fibronectin Fragments on the Transendothelial Migration of HIV-Infected Leukocytes and the Development of Subendothelial Foci of Infectious Leukocytes1 , 2004, The Journal of Immunology.

[49]  M. Jordana,et al.  Lung fibroblast clones from normal and fibrotic subjects differ in hyaluronan and decorin production and rate of proliferation. , 2004, The international journal of biochemistry & cell biology.

[50]  R. Rudolph,et al.  Killing of target cells by redirected granzyme B in the absence of perforin , 2004, FEBS Letters.

[51]  A. Desmoulière,et al.  Fibrillin‐1 and elastin are differentially expressed in hypertrophic scars and keloids , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[52]  S. Basinger,et al.  Decorin and suramin inhibit ocular fibroblast collagen production , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.

[53]  Arnold I. Caplan,et al.  Age-related Changes in the Proteoglycans of Human Skin , 2003, The Journal of Biological Chemistry.

[54]  M. Ebina,et al.  Intratracheal gene transfer of decorin reduces subpleural fibroproliferation induced by bleomycin. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[55]  R. Bleackley,et al.  Cytotoxic T lymphocytes: all roads lead to death , 2002, Nature Reviews Immunology.

[56]  M. Byrne,et al.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.

[57]  Y. Aso,et al.  Elevation of von Willebrand factor in plasma in diabetic patients with neuropathic foot ulceration , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[58]  A. Romano,et al.  Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. , 2002, The Journal of allergy and clinical immunology.

[59]  A. Utani,et al.  Deficiency of the decorin core protein in the variant form of Ehlers-Danlos syndrome with chronic skin ulcer. , 2001, Journal of dermatological science.

[60]  P. Sime,et al.  Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[61]  Jerome F. Strauss,et al.  The Extra Domain A of Fibronectin Activates Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[62]  M. Schmidt,et al.  Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. , 2001, American journal of respiratory and critical care medicine.

[63]  R. Burgeson,et al.  The importance of laminin 5 in the dermal-epidermal basement membrane. , 2000, Journal of dermatological science.

[64]  J. Norgauer,et al.  Plasminogen activation in venous leg ulcers , 2000, The British journal of dermatology.

[65]  C. Hack,et al.  Granzyme Activity in the Inflamed Lung Is Not Controlled by Endogenous Serine Proteinase Inhibitors1 , 2000, The Journal of Immunology.

[66]  T. Phillips,et al.  Level of Fibronectin mRNA Is Markedly Increased in Human Chronic Wounds , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[67]  A. Caplan,et al.  Age-related changes in the proteoglycans of human skin. , 2000, Archives of biochemistry and biophysics.

[68]  D. Yager,et al.  The proteolytic environment of chronic wounds , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[69]  I. K. Cohen,et al.  Interleukin-1alpha and collagenase activity are elevated in chronic wounds. , 1998, Plastic and reconstructive surgery.

[70]  M. Horan,et al.  Age‐related changes in the temporal and spatial distributions of fibrillin and elastin mRNAS and proteins in acute cutaneous wounds of healthy humans , 1997, The Journal of pathology.

[71]  Renato V. Iozzo,et al.  Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.

[72]  T. Ley,et al.  Long-range disruption of gene expression by a selectable marker cassette. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[73]  L. Sower,et al.  Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines. , 1996, Cellular immunology.

[74]  C. McCollum,et al.  Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions. , 1996, The Journal of investigative dermatology.

[75]  Y. Yazaki,et al.  Stimulation and priming of human neutrophils by IL-1 alpha and IL-1 beta: complete inhibition by IL-1 receptor antagonist and no interaction with other cytokines. , 1995, Experimental hematology.

[76]  J. Uitto,et al.  Differential expression of the versican and decorin genes in photoaged and sun-protected skin. Comparison by immunohistochemical and northern analyses. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[77]  H. Macdonald,et al.  Granzyme A is an interleukin 1 beta-converting enzyme , 1995, The Journal of experimental medicine.

[78]  J. Trapani,et al.  Granzymes: exogenous proteinases that induce target cell apoptosis. , 1995, Immunology today.

[79]  P. Henkart.  Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. , 1994, Immunity.

[80]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[81]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[82]  D. Hudig,et al.  Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. , 1993, Journal of immunology.

[83]  F. Grinnell,et al.  Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. , 1992, The Journal of investigative dermatology.

[84]  N H Sigal,et al.  Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity. , 1991, The Journal of biological chemistry.

[85]  F. Grinnell,et al.  Fibronectin profiles in normal and chronic wound fluid. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[86]  R. Clark.  Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. , 1990, The Journal of investigative dermatology.

[87]  R. Clark,et al.  Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. , 1988, The Journal of biological chemistry.

[88]  C. Lobe,et al.  Isolation of two cDNA sequences which encode cytotoxic cell proteases , 1988, FEBS letters.

[89]  M. Kramer,et al.  Are proteinases functional molecules of T lymphocytes? , 1987, Immunology today.

[90]  H. Simon,et al.  Purification and characterization of a T cell specific serine proteinase (TSP‐1) from cloned cytolytic T lymphocytes. , 1986, The EMBO journal.

[91]  Chau‐Ching Liu,et al.  Isolation and characterization of a serine esterase from cytolytic T cell granules , 1986, Cell.

[92]  F. Denizot,et al.  The inducible cytotoxic T-lymphocyte-associated gene transcript CTLA-1 sequence and gene localization to mouse chromosome 14 , 1986, Nature.

[93]  J. Tschopp,et al.  Granules of cytolytic T‐lymphocytes contain two serine esterases. , 1986, The EMBO journal.

[94]  H. Eisen,et al.  A novel serine esterase expressed by cytotoxic T lymphocytes , 1985, Nature.

[95]  R. Clark,et al.  Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. , 1982, Journal of immunology.

[96]  K. Burnand,et al.  THE CAUSE OF VENOUS ULCERATION , 1982, The Lancet.

[97]  J. Bowersox,et al.  Chemotaxis of aortic endothelial cells in response to fibronectin. , 1982, Cancer research.

[98]  G. Balian,et al.  Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment , 1981, The Journal of experimental medicine.

[99]  A. Grayzel,et al.  A cytotoxic proteinase isolated from human lymphocytes. , 1978, Journal of immunology.